Autism Speaks

Vanderbilt researchers Beth Malow, MD, MS, left, Maria Niarchou, PhD, and Lea Davis, PhD, hope to create a genetic risk profile of insomnia in autism spectrum disorder to better inform treatments.

Study explores genetic risk profiling of insomnia in autism

Vanderbilt researchers are studying how genes affect sleep and circadian disturbances in autism spectrum disorder (ASD) with a goal of creating a genetic risk profile of insomnia in ASD.

autism concept: puzzle

Study may point to new treatment approach for ASD

Using sophisticated genome mining and gene manipulation techniques, researchers at Vanderbilt University Medical Center (VUMC) have solved a mystery that could lead to a new treatment approach for autism spectrum disorder (ASD).

Study reveals possible ‘dimmer switch’ drug for Rett syndrome

Researchers at Vanderbilt University Medical Center have relieved symptoms in a mouse model of Rett syndrome with a drug-like compound that works like the dimmer switch in an electrical circuit.

Autism Speaks lauds Camarata’s contributions, years of support

Stephen Camarata, Ph.D., professor of Hearing and Speech Sciences, has been honored by Autism Speaks, a national autism advocacy and research organization, for dedicated service.

puzzel pieces, autism

VU receives grant renewal from Autism Speaks

Autism Speaks is renewing Vanderbilt University as an Autism Treatment Network (ATN) site with a three-year, $420,000 grant.

Sanders named TRIAD’s new medical director

Kevin Sanders, M.D., assistant professor of Psychiatry and Pediatrics, has been named medical director for the Treatment and Research Institute for Autism Spectrum Disorders (TRIAD).